Acute effects of viral respiratory tract infections on sputum bacterial density during CF pulmonary exacerbations

被引:26
作者
Chin, Melanie [1 ]
De Zoysa, Maya [1 ]
Slinger, Robert [2 ]
Gaudet, Ena [3 ]
Vandemheen, Katherine L. [3 ]
Chan, Francis [2 ]
Hyde, Lucie [2 ]
Mah, Thien-Fah [1 ]
Ferris, Wendy [2 ]
Mallick, Ranjeeta [3 ]
Aaron, Shawn D. [3 ]
机构
[1] Univ Ottawa, Dept Med, Ottawa, ON K1H 8L6, Canada
[2] Univ Ottawa, Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada
[3] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON K1H 8L6, Canada
关键词
Cystic fibrosis; Pseudomonas aeruginosa; Viral infection; CF exacerbation; CYSTIC-FIBROSIS; PSEUDOMONAS-AERUGINOSA; INTRAVENOUS ANTIBIOTICS; ADULT PATIENTS; RHINOVIRUS; VIRUSES; IMPACT;
D O I
10.1016/j.jcf.2014.11.009
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Airway proliferation of Pseudomonas aeruginosa bacteria is thought to trigger CF exacerbations and may be affected by the presence of viral infections. Methods: A 2-year prospective study was conducted on 35 adults with CF. P. aeruginosa sputum density was analyzed during stable, exacerbation and post exacerbation assessments. Upon exacerbation, samples were sent for PCR detection of respiratory viruses and the sputum density of P. aeruginosa in patients with a viral infection versus those without was compared. Results: Twenty-two patients experienced 30 exacerbations during the study period; 50% were associated with a viral infection. There was no change in sputum density of P. aeruginosa from the stable to exacerbation state when measured by quantitative culture or by PCR. Virus-associated exacerbations did not result in significant increases in P. aeruginosa sputum density compared to non-viral exacerbations. Conclusion: Sputum density of P. aeruginosa was not increased at the time of CF exacerbation and was not influenced by the presence of viral infection. (C) 2014 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:482 / 489
页数:8
相关论文
共 29 条
  • [1] Adult cystic fibrosis exacerbations and new strains of Pseudomonas aeruginosa
    Aaron, SD
    Ramotar, K
    Ferris, W
    Vandemheen, K
    Saginur, R
    Tullis, E
    Haase, D
    Kottachchi, D
    St Denis, M
    Chan, F
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 169 (07) : 811 - 815
  • [2] Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial
    Aaron, SD
    Vandemheen, KL
    Ferris, W
    Fergusson, D
    Tullis, E
    Haase, D
    Berthiaume, Y
    Brown, N
    Wilcox, P
    Yazghatlian, V
    Bye, P
    Bell, S
    Chan, F
    Rose, B
    Jeanneret, A
    Stephenson, A
    Noseworthy, M
    Freitag, A
    Paterson, N
    Doucette, S
    Harbour, C
    Ruel, M
    MacDonald, N
    [J]. LANCET, 2005, 366 (9484) : 463 - 471
  • [3] [Anonymous], 1994, Microbiology and infectious disease in cystic fibrosis, P1
  • [4] Identification of Pseudomonas aeruginosa by a duplex real-time polymerase chain reaction assay targeting the ecfX and the gyrB genes
    Anuj, Snehal N.
    Whiley, David M.
    Kidd, Timothy J.
    Bell, Scott C.
    Wainwright, Claire E.
    Nissen, Michael D.
    Sloots, Theo P.
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2009, 63 (02) : 127 - 131
  • [5] Impact of recent pulmonary exacerbations on quality of life in patients with cystic fibrosis
    Britto, MT
    Kotagal, UR
    Hornung, RW
    Atherton, HD
    Tsevat, J
    Wilmott, RW
    [J]. CHEST, 2002, 121 (01) : 64 - 72
  • [6] Microbiology of sputum from patients at cystic fibrosis centers in the United States
    Burns, JL
    Emerson, J
    Stapp, JR
    Yim, DL
    Krzewinski, J
    Louden, L
    Ramsey, BW
    Clausen, CR
    [J]. CLINICAL INFECTIOUS DISEASES, 1998, 27 (01) : 158 - 163
  • [7] Carmody Lisa A, 2013, Ann Am Thorac Soc, V10, P179, DOI 10.1513/AnnalsATS.201211-107OC
  • [8] Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis
    de Boer, Kaissa
    Vandemheen, Katherine L.
    Tullis, Elizabeth
    Doucette, Steve
    Fergusson, Dean
    Freitag, Andreas
    Paterson, Nigel
    Jackson, Mary
    Lougheed, M. Diane
    Kumar, Vijay
    Aaron, Shawn D.
    [J]. THORAX, 2011, 66 (08) : 680 - 685
  • [9] The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation
    Etherington, C.
    Naseer, R.
    Conway, S. P.
    Whitaker, P.
    Denton, M.
    Peckham, D. G.
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2014, 13 (01) : 49 - 55
  • [10] Incidence and clinical impact of respiratory viruses in adults with cystic fibrosis
    Flight, William G.
    Bright-Thomas, Rowland J.
    Tilston, Peter
    Mutton, Kenneth J.
    Guiver, Malcolm
    Morris, Julie
    Webb, A. Kevin
    Jones, Andrew M.
    [J]. THORAX, 2014, 69 (03) : 247 - 253